You just read:

Biocept and UT Southwestern Medical Center Announce Clinical Study to Profile and Monitor Non-Small Cell Lung Cancer Patients with ALK Rearrangements

News provided by

Biocept, Inc.

Aug 17, 2017, 08:05 ET